Pharmally International Holding Company Limited

6452

KYG7060F1019

Pharmally International Holding Company Limited completed the acquisition of PT. Biotis Prima Agrisindo.

July 31, 2016

Pharmally International Holding Company Limited (TSEC:6452) agreed to acquire PT. Biotis Prima Agrisindo for zero consideration on July 12, 2016. The transaction is expected to complete in July 2016. Pharmally International Holding Company Limited (TSEC:6452) completed the acquisition of PT. Biotis Prima Agrisindo in July, 2016.

Latest news about Pharmally International Holding Company Limited

Pharmally International Holding Company Limited(TSEC:6452) dropped from S&P Global BMI Index	30/20/30	CI
Pharmally International Holding Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2020	14/20/14	CI
Pharmally International Holding Company Limited Reports Earnings Results for the Full Year Ended December 31, 2019	31/20/31	CI
Pharmally International Holding Company Limited Reports Earnings Results for the Third Quarter Ended September 30, 2019	14/19/14	CI
Pharmally International Holding Company Limited Reports Earnings Results for the Second Quarter Ended June 30, 2019	13/19/13	CI
Pharmally International Holding Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2019	15/19/15	CI
Pharmally International Holding Co Ltd Reports Earnings Results for the Full Year Ended December 31, 2018	22/19/22	CI
Pharmally International Holding Company Limited announced that it has received TWD 1.17 billion in funding	27/17/27	CI
Pharmally International Holding Company Limited completed the acquisition of PT. Biotis Prima Agrisindo.	31/16/31	CI
Pharmally International Holding Company Limited agreed to acquire PT. Biotis Prima Agrisindo for zero consideration.	12/16/12	CI
Pharmally International Holding Company Limited(TSEC:6452) added to MSCI Acwi + Frontier Markets(acwi Fm) All Cap Index	01/15/01	CI
Pharmally International Holding Company Limited(TSEC:6452) added to S&P Global BMI Index	21/15/21	CI
Pharmally International Holding Company Limited's Equity Buyback announced on May 13, 2015 has expired.	13/15/13	CI
Pharmally International Holding Company Limited(TSEC:6452) added to Russell Global Index	29/15/29	CI
Pharmally International Holding Company Limited(TSEC:6452) added to Taiwan TAIEX Index	12/15/12	CI
Pharmally International Holding Company Limited announces an Equity Buyback for 2,000,000 shares, representing 3.08% for TWD 1,871.54 million.	13/15/13	CI
Pharmally International Holding Company Limited authorizes a Buyback Plan.	13/15/13	CI

Chart Pharmally International Holding Company Limited

Duration

Period

Chart Pharmally International Holding Company Limited

More charts

Company Profile

Pharmally International Holding Co Ltd is a Taiwan-based company primarily engaged in the production and sale of large volume injection and active pharmaceutical ingredients. It primarily produces large volume injection, including glass bottles, plastic bottles and non-polyvinyl chloride soft bags, and active pharmaceutical ingredients, such as nikethamide and levofloxacin lactate. It products sites are based in Mainland China.

Sector

Pharmaceuticals

More about the company

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD.	+16.31%	42.32B
OTSUKA HOLDINGS CO., LTD.	+16.11%	21.29B
SANDOZ GROUP AG	+19.33%	15.29B
CIPLA LIMITED	+18.71%	14.36B
ZYDUS LIFESCIENCES LIMITED	+52.78%	12.81B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-12.40%	6.58B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+14.28%	5.51B

Generic Pharmaceuticals